Biotech Peer Re­view: Ma­gen­ta on­boards five new VPs; BioIn­vent is hunt­ing for a new CEO

→ Fol­low­ing a $50 mil­lion se­ries B in April, stem cell trans­plan­ta­tion start­up Ma­gen­ta Ther­a­peu­tics is fill­ing some key roles in its lead­er­ship team. The com­pa­ny is tak­ing on four new vice pres­i­dents and a se­nior vice pres­i­dent: Char­lotte Mc­Don­agh, VP, bio­ther­a­peu­tics; Cindy Driscoll, VP, fi­nance; Karen Nichols, VP, reg­u­la­to­ry and qual­i­ty; Man­isha Pai, VP, in­vestor re­la­tions and com­mu­ni­ca­tions; and Zo­ran Zdraves­ki, SVP, chief le­gal of­fi­cer and cor­po­rate sec­re­tary.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.